4/A//SEC Filing
Hrkac Frederick 4/A
Accession 0001185185-23-000398
CIK 0001530766other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 4:30 PM ET
Size
5.4 KB
Accession
0001185185-23-000398
Insider Transaction Report
Form 4/AAmended
Hrkac Frederick
Director
Transactions
- Award
Common Stock
2023-02-24+16,000→ 61,455 total
Footnotes (2)
- [F1]The shares of restricted stock were granted in lieu of remuneration for the Company's 2022 fourth quarter board fees and shall be fully vested as of February 24, 2023, the date of the grant, based on a closing price of $1.19 per share on such date.
- [F2]On February 28, 2023, the reporting person filed a Form 4 which inadvertently reported a grant of 12,000 shares of restricted stock in lieu of remuneration for the Company's 2022 fourth quarter board fees when in fact, as reported in this amendment, the reporting person was granted 16,000 shares of restricted stock, and therefore beneficially owned 61,455 shares following the reported transaction.
Documents
Issuer
BioSig Technologies, Inc.
CIK 0001530766
Entity typeother
Related Parties
1- filerCIK 0001933130
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 4:30 PM ET
- Size
- 5.4 KB